Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytictissue factor activation is mediated by the depressed receptor expression in THP-1 cells
Aj. Chu et al., Blockade by polyunsaturated n-3 fatty acids of endotoxin-induced monocytictissue factor activation is mediated by the depressed receptor expression in THP-1 cells, J SURG RES, 87(2), 1999, pp. 217-224
Background. Monocytic hypercoagulation often occurs in inflammatory conditi
ons. We have previously reported that polyunsaturated n-3 fatty acids (n-3
FA) including eicosapentaenoic acid (20:5) and docosahexaenoic acid (22:6)
prevent the activation of monocytic tissue factor (TF) induced by bacterial
endotoxin lipopolysaccharide (LPS)I in cell cultures and animals.
Hypothesis. We herein explore the mode of inhibitory action of n-3 FA to de
termine if LPS transmembrane signaling is blocked, exerting such antagonism
.
Results. Exposure of human leukemia monocytic THP-1 cells to bacterial endo
toxin (Escherichia coli 0111:B04, 1.5 mu g/ml) for 6 h significantly activa
ted TF activity and the production of nitric oxide (NO), tumor necrosis fac
tor LY (TNF-alpha), and interleukin (IL)-1 beta in conditioned medium. Pret
reatment with n-3 FA, 20:5 and 22:6 at 10 mu M, resulted in time-dependent
suppression of not only TF activation but also the elicitation of NO, TNF-a
lpha, and IL-1 beta, These LPS responses were substantially depressed by mo
re than 50% after a 72-h pretreatment. FACScan analysis showed that n-3 FA
readily prevented fluorescein isothiocyanate (FITC)conjugated LPS from bind
ing to THP-1 cells by approximately 70%. The observation that anti-CD14 mAb
diminished FITC-LPS binding in a dose-dependent fashion has revealed CD14
dependency in LPS recognition. LPS upregulated CD14 expression, which was s
ignificantly arrested by n-3 FA, Similarly, the upregulation of the express
ion of CD11b, another proposed LPS receptor, was also minimally but signifi
cantly depressed by n-3 FA.
Conclusion. The present study demonstrates that n-3 FA are able to block LP
S transmembrane signaling via suppression of the receptor upregulation, med
iating a variety of significant antagonisms against LPS action. (C) 1999 Ac
ademic Press.